Multiplatinum resistance and metabolic plasticity in metastatic castration resistant prostate cancer (CRPC) and colorectal cancer (CRC)

  • No Comments

Multiplatinum resistance and metabolic plasticity in metastatic castration resistant prostate cancer (CRPC) and colorectal cancer (CRC)

Multiplatinum resistance and metabolic plasticity in metastatic castration resistant prostate cancer (CRPC) and colorectal cancer (CRC) 1125 1625 Metabolism & Cancer
Leave a Reply
In-silico analysis of identified proteins from HER-2 positive breast cancer cell lines resistant and sensitive to Trastuzumab treatment
FABP4 and FABP5 play an important role in breast cancer progession
The role of adipocyte G0/G1 Switch Gene 2 (G0S2) in the crosstalk between cancer cells and adipocytes
Mitochondrial complex I null cancer models reveal unspecific antiproliferative effects of complex I inhibitors – Copie
Enter your
text here